Our publication list includes original research articles and review articles authored by members of our team, partners, and others, all of which include data or discussions relevant to our pipeline programs and technology.
The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine Vaccine May 2023
Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States Vaccine May 2023
Immunogenicity and safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine; A Phase 3 Randomized Clinical Trial The Journal of the American Medical Association Network Open October 2021
Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants bioRxiv September 2021
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits potent immunity after a single dose Vaccine July 2021
Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: a Phase 3 randomized clinical trial Vaccine June 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a raondomised, double-blind phase 3 trial The Lancet Infectious Diseases May 2021
Immunogenicity of Sci-B-Vac (a Third-Generation Hepatitis B Vaccine) in HIV-Positive Adults Israel Medical Association Journal March 2021
Rapid and high seroprotection rates achieved with a tri-antigenic hepatitis B vaccine in healthy young adults: Results from a Phase IV Study Vaccine February 2021
Efficacy and Safety of a 3-antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation Clinical Infectious Diseases October 2020
Prophylactic Vaccination Against Hepatitis B: Achievements, Challenges, and Perspectives Medical Microbiology and Immunology February 2015
Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine Medical Microbiology and Immunology January 2015
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine Vaccine September 2014
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity Clinical and Vaccine Immunology February 2014
Randomized Controlled Study Investigating Viral Suppression and Serological Response Following Pre-S1/Pre-S2/S Vaccine Therapy Combined with Lamivudine Treatment in HbeAg-Positive Patients with Chronic Hepatitis B Antimicrobial Agents and Chemotherapy December 2009
PreS1 epitope recognition in nerborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen Virology Journal January 2009
Cellular and humoral immune response to a third generation hepatitis B vaccine Journal of Viral Hepatitis August 2007
Comparative Immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine Vaccine April 2006
Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease Nephron Clinical Practice June 2004
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S2 and pre-S2 antigens as compared with conventional yeast-derived vaccines Nephron Clinical Practice June 2004
Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine Medical Science Monitor January 2004
Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates Israel Medical Association Journal May 2001
Rapid Seroprotection against Hepatitis B following the First Dose of a Pre-S1/Pre-S2/S vaccine Journal of Hepatology January 2001
Safety and Immunogenicity of a New Mammalian Cell-Derived Recombinant Hepatitis B Vaccine Containing Pre-S1 and Pre-S2 Antigens in Adults Israel Medical Association Journal June 1997
